524804:BOM
Aurobindo Pharma Ltd
Rs 1.675,00
arrow_upward
+0,82%(+13,65) 1 HR
15 Okt, 15.30.00 GMT+5.30 · INR
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk 524804...
Pembukaan
Rs 1.645,00
Tinggi
Rs 1.684,80
Rendah
Rs 1.645,00
Kapitalisasi pasar
965,43Â M
Volume rata-rata
24,93Â rb
Volume
168,00Â rb
Rasio P/E
26,17
Harga tinggi dalam 52 minggu terakhir
Rs 1.739,95
Harga rendah dalam 52 minggu terakhir
Rs 1.080,10
EPS
Rs 64,00
Saham beredar
585,90Â jt
Jumlah karyawan
29Â rb
Pembukaan
Rs 1.645,00
Tinggi
Rs 1.684,80
Rendah
Rs 1.645,00
Kapitalisasi pasar
965,43Â M
Volume rata-rata
24,93Â rb
Volume
168,00Â rb
Rasio P/E
26,17
Harga tinggi dalam 52 minggu terakhir
Rs 1.739,95
Harga rendah dalam 52 minggu terakhir
Rs 1.080,10
EPS
Rs 64,00
Saham beredar
585,90Â jt
Jumlah karyawan
29Â rb
Artikel berita
Dari sumber web dan partner berita
Moneycontrol.com
·
1 hari yang lalu
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
Profil
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
Tentang Aurobindo Pharma Ltd
CEO-
Karyawan29,2Â rb
Didirikan1986
Kantor PusatHaiderabad, Andhra Pradesh, India
Sektor-
Situsaurobindo.com